Trials / Sponsors / Q32 Bio Inc.
Q32 Bio Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN IgA Nephropathy, Lupus Nephritis (LN), C3 (Complement Component 3) Glomerulopathy | Phase 2 | 2024-06-27 |
| Active Not Recruiting | A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL Alopecia Areata | Phase 2 | 2023-09-12 |
| Active Not Recruiting | Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD) Atopic Dermatitis | Phase 2 | 2022-09-30 |
| Completed | Single and Multiple Ascending Dose Study of ADX-914 in Healthy Adult Volunteers Safety Issues | Phase 1 | 2020-09-08 |